Gaithersburg Vaccine Development Company Testing Candidate for COVID-19
A vaccine development company headquartered in Gaithersburg is starting clinical trials for a potential COVID-19 vaccine. Novavax will administer the trials for vaccine candidate NVX‑CoV2373 in two phases, a statement… Read More
